Latest profit margin for Medpace Holdings: 17.67% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Medpace Holdings's profit margin stands at 17.67% as of June 2026. That compares with 18.74% in the prior-year period — down 5.8% year over year. That is above the Healthcare sector average of 14.41%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Medpace Holdings reported 17.67% in profit margin versus 18.74% a year earlier — a 5.8% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.
Medpace Holdings sits higher the Healthcare benchmark (14.41%) with a profit margin of 17.67%. That is roughly 22.5% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
A profit margin of 17.67% for Medpace Holdings means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.
The history chart shows how Medpace Holdings's profit margin evolved across reporting periods, while the comparison chart places MEDP next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.